Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Genentech, Inc

Article Abstract:

A comparative analysis of the company sales and financial details of Genetech, Inc. from 1994 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Genentech Inc

Article Abstract:

Genentech Inc. achieved a 25% average in annal profit growth, expected to continue to 2005. Equity is timely and offers decent capital appreciation potential to 2006-2008.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Product information, Forecasts, trends, outlooks, Financial management, Labor Distribution by Employer, Finance, Company investment, Investments, Statistics, GNE, Company business forecast/projection, Company forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Genentech, Inc

Article Abstract:

The price appreciation potential of Genentech, Inc. for the years 2010-2012 is discussed. The San Francisco, California-based company produces drugs for cancer and asthma.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Stocks, Stock prices

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Biological products industry, Securities, Company sales and earnings, Company earnings/profit, Genentech Inc., Company securities, DNA
Similar abstracts:
  • Abstracts: Ametek Inc. Startek Inc
  • Abstracts: Imclone Systems Inc. Exelixis Inc
  • Abstracts: Exelixis, Inc. Exelixis Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.